IPS35-2-R
AHQUi001-A-1
General#
Cell Line |
|
| hPSCreg Name | AHQUi001-A-1 |
| Alternative name(s) |
IPS35-2-R
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Last update | 12th February 2021 |
| User feedback | |
Provider |
|
| Generator | Affiliated Hospital of Qingdao University (AHQU) |
| Distributors | |
External Databases |
|
| BioSamples | SAMEA7655488 |
| Cellosaurus | CVCL_A1MV |
| Wikidata | Q102113510 |
General Information |
|
| Publications | |
| * Is the cell line readily obtainable for third parties? |
No |
| Subclone of | |
Donor Information#
General Donor Information |
|
| Sex | male |
| Ethnicity | Chinese Han |
Phenotype and Disease related information (Donor) |
|
| Diseases | A disease was diagnosed.
|
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
External Databases (Donor) |
|
| BioSamples | SAMEA6516985 |
Ethics#
Also have a look at the ethics information for the parental line
AHQUi001-A
.
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation#
General |
|
|
The source cell information can be found in the parental cell line
AHQUi001-A.
|
|
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Episomal |
| Genes | |
| Is reprogramming vector detectable? |
No |
| Methods used |
PCR
|
Vector free reprogramming |
|
Other |
|
| Derived under xeno-free conditions |
Unknown |
| Derived under GMP? |
Unknown |
| Available as clinical grade? |
Unknown |
Culture Conditions#
| Surface coating | Matrigel/Geltrex |
| Feeder cells |
No |
| Passage method |
Enzyme-free cell dissociation
EDTA
|
| CO2 Concentration | 5 % |
| Medium |
mTeSR™ 1
|
Characterisation#
No characterisation data could be found for this subclone. Please open parental cell line AHQUi001-AGenotyping#
Karyotyping (Cell Line) |
|
Other Genotyping (Cell Line) |
Genetic Modification#
| Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.